Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 6 Months Ended
Mar. 29, 2020
Mar. 31, 2019
Operating Activities:    
Net Income $ 1,393 $ 1,731
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 691 698
Income tax provision less than income tax payments (350) (958)
Non-cash portion of share-based compensation expense 603 452
Net gains on marketable securities and other investments (49) (9)
Indefinite and long-lived asset impairment charges 0 203
Impairment losses on other investments 337 69
Other items, net (75) (190)
Changes in assets and liabilities:    
Accounts receivable, net (607) 200
Inventories (297) (49)
Other assets (71) 25
Trade accounts payable 755 (173)
Payroll, benefits and other liabilities 24 (727)
Unearned revenues (153) (122)
Net Cash Provided by Operating Activities 2,201 1,150
Investing Activities:    
Capital expenditures (641) (322)
Payments to Acquire Marketable Securities (1,312) 0
Proceeds from sales and maturities of debt and equity marketable securities 256 96
Acquisitions and other investments, net of cash acquired (128) (118)
Other items, net 56 83
Net Cash Used by Investing Activities (1,769) (261)
Financing Activities:    
Proceeds from short-term debt 1,116 3,297
Repayment of short-term debt (1,116) (3,303)
Proceeds from issuance of common stock 174 177
Repurchases and retirements of common stock (2,340) (1,019)
Dividends paid (1,415) (1,502)
Payments of tax withholdings related to vesting of share-based awards (232) (143)
Other items, net (55) (38)
Net Cash Used by Financing Activities (3,868) (2,531)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net decrease in total cash and cash equivalents (3,436) (1,642)
Total cash and cash equivalents at beginning of period 11,839 11,777
Total cash and cash equivalents at end of period $ 8,403 $ 10,135